You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

Litigation Details for Puma Biotechnology, Inc. v. AstraZeneca Pharmaceuticals LP (D. Del. 2021)

✉ Email this page to a colleague

« Back to Dashboard

Puma Biotechnology, Inc. v. AstraZeneca Pharmaceuticals LP (D. Del. 2021)

Docket	⤷ Sign Up	Date Filed	2021-09-22
Court	District Court, D. Delaware	Date Terminated
Cause	35:1 Patent Infringement	Assigned To	Colm Felix Connolly
Jury Demand	Plaintiff	Referred To
Parties	ASTRAZENECA PLC
Patents	10,035,788; 7,399,865; 7,982,043; 8,518,446; 8,790,708; 8,946,235; 9,139,558; 9,630,946; 9,732,058
Attorneys	Kaveh V. Saba
Firms	Morris, Nichols, Arsht & Tunnell
Link to Docket	External link to docket

Small Molecule Drugs cited in Puma Biotechnology, Inc. v. AstraZeneca Pharmaceuticals LP

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up and ⤷ Sign Up .

Details for Puma Biotechnology, Inc. v. AstraZeneca Pharmaceuticals LP (D. Del. 2021)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2024-05-12	433	Exhibit to a Document	PUMAWYETH-TAG00034374 PUMAWYETH-TAG00034412 U.S. Pat. No. 10,035,788 (Lu) - Maleate Salts Family … Scanned Patent Deed - U.S. Patent No. 10,603,314 (Mar. 31, 2020) … Scanned Patent Deed - U.S. Patent No. 10,596,162 (Mar. 24, 2020) … USPTO, Patent Examiner and Flow of an Application, Patent Training Academy Entry Level… Ribbon Copy - U.S. Patent No. 10,603,314 (Mar. 31, 2020)	External link to document
2024-05-12	434	Exhibit to a Document	AZ-PW-TAG00007824 U.S. Pat. No. 7,399,865 (Wissner) (July 15, 2008) …AZ-PW-TAG00008187 AZ-PW-TAG00008202 U.S. Patent Application Publication No. 2004/0067942 (Elliott…AZ-PW-TAG00422969 AZ-PW-TAG00422986 Patents 571 (1997) …-TAG00424627 AZ-PW-TAG00424648 U.S. Patent No. 8,022,216 …22 September 2021 1:21-cv-01338 830 Patent Plaintiff District Court, D. Delaware	External link to document
2021-11-05	8	Answer to Complaint	. RESPONSE: Defendants admit that U.S. Patent Nos. 8,946,235 and 9,732,058 are listed in the FDA Orange…. RESPONSE: Defendants admit that U.S. Patent Nos. 8,946,235 and 9,732,058 are listed in the FDA Orange…U.S. Patent No. 10,603,314 (the “’314 Patent”) and U.S. Patent No. 10,596,162 (the “’162 Patent”) (collectively…United States Patent Nos. 10,603,314 (“the ’314 patent”) and 10,596,162 (“the ’162 patent”) (collectively…causes of action for patent infringement of U.S. Patent Nos. 10,603,314 (“the ’314 Patent”) and 10,596,162	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.